HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target

被引：27

作者：

Srinivasan, Madhuwanti ^{[1
]}

Banerjee, Souresh ^{[1
]}

Palmer, Allison ^{[1
]}

Zheng, Guoxing ^{[1
]}

Chen, Aoshuang ^{[1
]}

Bosland, Maarten C. ^{[2
]}

Kajdacsy-Balla, Andr ^{[2
]}

Kalyanasundaram, Ramaswamy ^{[1
]}

Munirathinam, Gnanasekar ^{[1
,3
]}

机构：

[1] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA

[2] Univ Illinois, Dept Pathol, Chicago, IL USA

[3] Univ Illinois, Ctr Canc, Chicago, IL USA

来源：

HORMONES & CANCER | 2014年 / 5卷 / 03期

关键词：

MOBILITY GROUP BOX-1; END-PRODUCTS RAGE; DNA-BINDING; CELL-DEATH; PROGESTERONE-RECEPTOR; CHROMATIN PROTEINS; MESSENGER-RNA; LETHAL SEPSIS; CALF-THYMUS; BETA-CELLS;

D O I：

10.1007/s12672-014-0175-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

High-mobility group box 1 (HMGB1) is a dynamic nuclear protein participating in transcription, chromatin remodelling, and DNA recombination and repair processes. Accumulating evidence indicates that its function now extends beyond the nucleus, notably its extracellular role in inflammation. HMGB1 is implicated as a late mediator of sepsis and is also believed to promote atherosclerosis and other inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus. Interestingly, deregulation of HMGB1 is shown to be associated with the hallmarks of cancer development. Moreover, several clinical studies have shown that HMGB1 is a promising biomarker for a variety of cancer types. In this review, we provide novel insights into the role and mechanisms of HMGB1, in particular, to hormone-related cancers and its potential to serve as a therapeutic target.

引用

页码：127 / 139

页数：13

共 50 条

[1] HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target
Madhuwanti Srinivasan
Souresh Banerjee
Allison Palmer
Guoxing Zheng
Aoshuang Chen
Maarten C. Bosland
André Kajdacsy-Balla
Ramaswamy Kalyanasundaram
Gnanasekar Munirathinam
Hormones and Cancer, 2014, 5 : 127 - 139
[2] HMGB1 as a potential therapeutic target for sepsis
Wang, Haichao
Zhu, Shu
Sama, Andrew E.
INFLAMMATION RESEARCH, 2010, 59 : S146 - S146
[3] HMGB1 as the therapeutic target in gastric cancer
Takaki, Wataru
Konishi, Hirotaka
Arita, Tomohiro
Kosuga, Toshiyuki
Shiozaki, Atsushi
Nakanishi, Masayoshi
Kubota, Takeshi
Fujiwara, Hitoshi
Okamoto, Kazuma
Otsuji, Eigo
CANCER SCIENCE, 2021, 112 : 429 - 429
[4] HMGB1 as a Potential Therapeutic Target for Neuropathic Pain
Maeda, Takehiko
Ozaki, Masanobu
Kobayashi, Yuka
Kiguchi, Norikazu
Kishioka, Shiroh
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 123 (04) : 301 - 305
[5] HMGB1: A Promising Therapeutic Target for Prostate Cancer
Gnanasekar, Munirathinam
Kalyanasundaram, Ramaswamy
Zheng, Guoxing
Chen, Aoshuang
Bosland, Maarten C.
Kajdacsy-Balla, Andre
PROSTATE CANCER, 2013, 2013
[6] HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
Wang, Yanbin
Jiang, Zhaoqiang
Yan, Jianing
Ying, Shibo
DISEASE MARKERS, 2019, 2019
[7] HMGB1 as a therapeutic target in disease
Xue, Jiaming
Suarez, Joelle S.
Minaai, Michael
Li, Shuangjing
Gaudino, Giovanni
Pass, Harvey I.
Carbone, Michele
Yang, Haining
JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (05) : 3406 - 3419
[8] HMGB1 as a cytokine and therapeutic target
Yang, H
Wang, HC
Czura, CJ
Tracey, KJ
JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (06): : 469 - 472
[9] HMGB1 is a therapeutic target for leukemia
Yu, Yan
Xie, Min
Kang, Rui
Livesey, Kristen M.
Cao, Lizhi
Tang, Daolin
AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (01): : 36 - 43
[10] HMGB1: A novel, potential therapeutic target in the treatment of cardiac fibrosis?
Dai, Bo
Tian, Bing
Gong, Ying
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 323 : 262 - 262

← 1 2 3 4 5 →